Scarica l'app Stockscreener
64.50
2.46%
1.55
Dopo l'orario di chiusura:
64.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by State Street Corp - Defense World
Disc Medicine (NASDAQ:IRON) Stock Price Down 3%Should You Sell? - MarketBeat
Disc medicine CEO sells shares worth $844,314 By Investing.com - Investing.com Australia
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $844,333.91 in Stock - MarketBeat
Disc medicine CEO sells shares worth $844,314 - Investing.com
Disc Medicine's SWOT analysis: rare blood disorder stock poised for growth - Investing.com
Y Intercept Hong Kong Ltd Takes Position in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
(IRON) Technical Data - Stock Traders Daily
Disc Medicine's SWOT analysis: stock potential amid mixed trial results - Investing.com
Disc Medicine's SWOT analysis: stock potential amid mixed trial results By Investing.com - Investing.com Canada
Fmr LLC Has $19.99 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Wellington Management Group LLP - MarketBeat
Verition Fund Management LLC Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Charles Schwab Investment Management Inc. Purchases 19,401 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) Target Price at $85.80 - MarketBeat
Disc Medicine (NASDAQ:IRON) Given Outperform Rating at Wedbush - Defense World
Disc Medicine Presents Positive Clinical and Translational - GlobeNewswire
Disc Medicine Unveils Breakthrough Clinical Results for Blood Disorder Portfolio at ASH 2024 - StockTitan
Disc Medicine (NASDAQ:IRON) Earns "Buy" Rating from HC Wainwright - MarketBeat
Disc Medicine's Myelofibrosis Drug Shows Breakthrough Results in Phase 1b Trial with 100% Response Rate - StockTitan
Disc Medicine Presents Positive Updated Results from Phase - GlobeNewswire
Janus Henderson Group PLC Raises Position in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Intech Investment Management LLC Buys New Shares in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine director White sells $126k in stock By Investing.com - Investing.com Nigeria
Disc Medicine director White sells $126k in stock - Investing.com India
HighVista Strategies LLC Invests $470,000 in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
S&P GS Excess Index (G7N22) Quote - The Globe and Mail
DJ Brent Crude Index (BBR) QuotePress Release - The Globe and Mail
Walleye Capital LLC Boosts Stake in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Ally Bridge Group NY LLC Has $4.91 Million Stake in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Disc Medicine maintains Buy rating with $111 target By Investing.com - Investing.com Canada
Disc Medicine chief medical officer sells $928k in stock - Investing.com India
Disc Medicine chief medical officer sells $928k in stock By Investing.com - Investing.com Nigeria
Disc Medicine, Inc. (NASDAQ:IRON) Holdings Trimmed by Eagle Asset Management Inc. - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Victory Capital Management Inc. - MarketBeat
Disc Medicine secures $200m financing to support trials - MSN
Contrasting Pharming Group (OTCMKTS:PHGUF) and Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine chief medical officer sells $546,152 in stock - Investing.com
Disc Medicine chief medical officer sells $546,152 in stock By Investing.com - Investing.com Canada
Disc Medicine Announces New Equity Sales Agreement - TipRanks
Cantor Fitzgerald Predicts Disc Medicine FY2024 Earnings - Defense World
FY2024 EPS Estimates for Disc Medicine Raised by Analyst - MarketBeat
Wedbush Forecasts Disc Medicine's Q4 Earnings (NASDAQ:IRON) - MarketBeat
Disc Medicine FY2024 EPS Estimate Raised by Leerink Partnrs - MarketBeat
Lifesci Capital Predicts Stronger Earnings for Disc Medicine - MarketBeat
Disc Medicine FY2024 EPS Forecast Boosted by HC Wainwright - MarketBeat
Paradigm Biocapital Advisors LP Adjusts Stake in Disc Medicine I - GuruFocus.com
Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) PT at $85.80 - MarketBeat
FY2028 Earnings Forecast for Disc Medicine Issued By Wedbush - MarketBeat
Disc Medicine Inc. (IRON) Quarterly 10-Q Report - Quartz
Disc Medicine Reports Q3 2024 Results and Strategic Progress - TipRanks
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):